Jeena Sikho Lifecare Ltd
NSE: JSLL BSE: 544476Healthcare
Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.
₹629
52W: ₹376 — ₹850
PE 38.3 · Book ₹28.4 · +2115% vs bookMarket Cap₹7,814 Cr
Stock P/E38.3Price to Earnings
ROCE50.2%Return on Capital
ROE37.9%Return on Equity
Div. Yield0.17%Face Value ₹2
Strengths
- +Company has delivered good profit growth of 72.8% CAGR over last 5 years
- +Company has a good return on equity (ROE) track record: 3 Years ROE 40.1%
Weaknesses
- −Stock is trading at 22.3 times its book value
- −Debtor days have increased from 54.0 to 76.0 days.
Shareholding Pattern
Promoters63.62%
FIIs6.17%
DIIs0.46%
Public29.77%
| Category | Nov 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 67.91% | 67.91% | 65.84%▼2.1 | 63.53%▼2.3 | 63.53% | 63.61%▲0.1 | 63.62%▲0.0 | 63.62% |
| FIIs | 1.79% | 0.26%▼1.5 | 4.05%▲3.8 | 5.95%▲1.9 | 5.91%▼0.0 | 6.59%▲0.7 | 6.31%▼0.3 | 6.17%▼0.1 |
| DIIs | 0% | 0% | 0.07%▲0.1 | 0.17%▲0.1 | 0.18%▲0.0 | 0.15%▼0.0 | 0.11%▼0.0 | 0.46%▲0.4 |
| Public | 30.3% | 31.83%▲1.5 | 30.04%▼1.8 | 30.34%▲0.3 | 30.38%▲0.0 | 29.65%▼0.7 | 29.97%▲0.3 | 29.77%▼0.2 |
Financial Statements
| Metric | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Sales | 100 | 114 | 116 | 139 | 174 | 190 | 222 |
| Expenses | 75 | 74 | 86 | 92 | 96 | 98 | 121 |
| Operating Profit | 25 | 40 | 30 | 47 | 79 | 92 | 101 |
| OPM % | 25% | 35% | 26% | 34% | 45% | 48% | 45% |
| Net Profit | 16 | 27 | 13 | 27 | 51 | 59 | 67 |
| EPS ₹ | 1.3 | 2.14 | 1.06 | 2.2 | 4.13 | 4.73 | 5.37 |
AI Insights
Revenue Trend
TTM revenue at ₹725Cr, up 54.6% YoY. OPM at 44%.
Debt Position
Borrowings at ₹106Cr. Debt-to-equity ratio: 0.32x. Healthy balance sheet.
Capex Cycle
CWIP at ₹17Cr (7% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0.46% (+0.46pp change). FIIs: 6.17% (+6.17pp change). Promoters hold 63.62%.
Margin & Efficiency
ROCE improving from 0% (Mar 2019) to 50% (Mar 2025). Working capital days: 55.
Valuation
PE 38.3x with 50.2% ROCE. Price is 2115% above book value of ₹28.4. Dividend yield: 0.17%.
Recent Announcements
- Revised Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015, As Amended ('SEBI Listing Regulations') - Sale Of Land 9 May - Jeena Sikho Lifecare approved sale of 48 bigha non-operational land in Patiala for ₹24 crore.
- Sale Of Land - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015. 8 May - Board approved sale of 48 bigha land in Punjab for ₹24 crore on 8 May 2026.
- Intimation For Appointment Of Investor Relations Management Agency Of The Company 4 May - Jeena Sikho Lifecare appoints GoIndia Advisors LLP as investor relations management agency.
- Jeena Sikho Lifecare Limited Has informed About Publication Of Case Study And Case Reports. 4 May - Seven case studies and two case reports published in JASE on Ayurvedic treatments.
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 16 Apr - Jeena Sikho Lifecare says it is not a Large Corporate for FY2026.
- Financial Year 2025 from bse
- Financial Year 2024 from nse
- Financial Year 2023 from nse